Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $47,511 | 16 | 59.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,659 | 11 | 34.8% |
| Travel and Lodging | $3,201 | 10 | 4.0% |
| Food and Beverage | $1,122 | 27 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $30,955 | 23 | $0 (2020) |
| HOLOGIC INC | $17,724 | 5 | $0 (2020) |
| Gen-Probe Sales & Service, Inc. | $12,909 | 3 | $0 (2018) |
| Gen-Probe, Inc. | $6,891 | 4 | $0 (2020) |
| DySIS Medical, Inc. | $5,214 | 2 | $0 (2019) |
| SCYNEXIS, Inc. | $3,955 | 9 | $0 (2022) |
| Cytyc Surgical Products, LLC | $1,174 | 2 | $0 (2018) |
| Agile Therapeutics, Inc. | $157.62 | 3 | $0 (2021) |
| TherapeuticsMD, Inc. | $154.71 | 7 | $0 (2020) |
| Duchesnay USA Incorporated | $125.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,555 | 8 | SCYNEXIS, Inc. ($2,555) |
| 2021 | $1,558 | 4 | SCYNEXIS, Inc. ($1,400) |
| 2020 | $10,365 | 10 | Gen-Probe, Inc. ($6,891) |
| 2019 | $9,433 | 14 | Merck Sharp & Dohme Corporation ($9,319) |
| 2018 | $26,147 | 17 | Gen-Probe Sales & Service, Inc. ($12,909) |
| 2017 | $29,436 | 11 | HOLOGIC INC ($16,412) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $11.28 | General |
| 10/07/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $7.48 | General |
| 06/17/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $4.06 | General |
| 06/14/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $7.11 | General |
| 04/12/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $31.26 | General |
| 03/11/2022 | SCYNEXIS, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| 03/02/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $26.65 | General |
| 01/31/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $17.61 | General |
| 12/04/2021 | SCYNEXIS, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 04/12/2021 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $123.44 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 04/08/2021 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 02/04/2021 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 11/02/2020 | Gen-Probe, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,625.00 | General |
| 09/02/2020 | TherapeuticsMD, Inc. | ANNOVERA (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 08/31/2020 | Gen-Probe, Inc. | — | Consulting Fee | Cash or cash equivalent | $546.88 | General |
| 07/15/2020 | TherapeuticsMD, Inc. | ANNOVERA (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 06/29/2020 | Gen-Probe, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,531.25 | General |
| 06/24/2020 | TherapeuticsMD, Inc. | ANNOVERA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 06/03/2020 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,065.00 | General |
| Category: VACCINE | ||||||
| 05/15/2020 | Gen-Probe, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,187.50 | General |
| 04/06/2020 | HOLOGIC INC | — | Consulting Fee | Cash or cash equivalent | $1,312.50 | General |
| 01/16/2020 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 11/06/2019 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 11/06/2019 | DySIS Medical, Inc. | Ultra 2.0 (Device) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: OBSTETRICS & GYNECOLOGY | ||||||
| 09/05/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 685 | 1,099 | $482,926 | $87,208 |
| 2022 | 11 | 657 | 992 | $336,550 | $90,881 |
| 2021 | 12 | 765 | 1,223 | $267,425 | $112,376 |
| 2020 | 12 | 567 | 872 | $187,340 | $70,117 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 56820 | Exam of external female genitals using an endoscope | Office | 2023 | 212 | 391 | $225,607 | $44,905 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 188 | 344 | $169,936 | $26,956 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $37,597 | $6,002 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 30 | $20,670 | $3,308 | 16.0% |
| 57421 | Biopsy of vagina and cervix using an endoscope | Office | 2023 | 12 | 15 | $12,390 | $2,600 | 21.0% |
| 56821 | Exam and biopsy of external female genitals using an endoscope | Office | 2023 | 13 | 13 | $10,075 | $2,114 | 21.0% |
| 87210 | Smear for infectious agents | Office | 2023 | 123 | 193 | $5,211 | $1,100 | 21.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 52 | 57 | $1,140 | $177.27 | 15.6% |
| 81015 | Urinalysis using microscope | Office | 2023 | 15 | 15 | $300.00 | $44.85 | 15.0% |
| 56820 | Exam of external female genitals using an endoscope | Office | 2022 | 191 | 340 | $154,639 | $40,913 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 164 | 290 | $88,908 | $22,761 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $30,508 | $8,821 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 26 | 26 | $10,292 | $4,005 | 38.9% |
| 56821 | Exam and biopsy of external female genitals using an endoscope | Office | 2022 | 22 | 22 | $11,350 | $3,769 | 33.2% |
| 57421 | Biopsy of vagina and cervix using an endoscope | Office | 2022 | 14 | 20 | $11,760 | $3,280 | 27.9% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 20 | 21 | $8,570 | $2,387 | 27.8% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 20 | 21 | $8,610 | $2,147 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $6,912 | $1,816 | 26.3% |
| 87210 | Smear for infectious agents | Office | 2022 | 104 | 154 | $4,386 | $884.22 | 20.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 23 | 25 | $615.00 | $99.66 | 16.2% |
| 56820 | Examination of external female genitals using an endoscope | Office | 2021 | 213 | 425 | $148,750 | $50,621 | 34.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 174 | 338 | $50,700 | $27,295 | 53.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 78 | 78 | $19,500 | $11,704 | 60.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 29 | 29 | $7,250 | $4,590 | 63.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 28 | $5,600 | $3,490 | 62.3% |
About Dr. Mark Spitzer, MD
Dr. Mark Spitzer, MD is a Obstetrics & Gynecology healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306819438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Spitzer, MD has received a total of $79,493 in payments from pharmaceutical and medical device companies, with $2,555 received in 2022. These payments were reported across 64 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($47,511).
As a Medicare-enrolled provider, Spitzer has provided services to 2,674 Medicare beneficiaries, totaling 4,186 services with total Medicare billing of $360,582. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location New Hyde Park, NY
- Active Since 02/09/2006
- Last Updated 03/24/2017
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306819438
Products in Payments
- GARDASIL (Biological) $28,890
- FETAL FIBRONECTIN (Device) $16,412
- DySIS V3 digital colposcope (Device) $5,200
- GARDASIL 9 (Biological) $2,065
- Aptima (Device) $237.00
- Twirla (Drug) $157.62
- Osphena (Drug) $125.00
- INGREZZA (Drug) $124.77
- IMVEXXY (Drug) $81.85
- ANNOVERA (Drug) $72.86
- Orilissa (Drug) $41.49
- Ultra 2.0 (Device) $13.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in New Hyde Park
Dr. Sara Farag, M.d, M.D
Obstetrics & Gynecology — Payments: $19,872
Dr. Evan Shapiro, M.d, M.D
Obstetrics & Gynecology — Payments: $11,838
Dr. Wendy Fried-Oginski, M.d, M.D
Obstetrics & Gynecology — Payments: $8,683
Dr. Steven Cohen, M.d, M.D
Obstetrics & Gynecology — Payments: $8,406
Dr. Nicole Bell, M.d, M.D
Obstetrics & Gynecology — Payments: $4,975
Tiffany Hunter, Md, MD
Obstetrics & Gynecology — Payments: $3,874